India's first intranasal vaccine for Covid gets DCGI approval

India's


New Delhi, Sep 6 : India's first intranasal Covid vaccine by Bharat Biotech on Tuesday got the approval from the Drug Controller General of India for 18+ age group for restricted use in emergency situation. Announcing the achievements, Union Health Minister Mansukh Mandaviya termed it a 'big boost to India's fight against Covid-19. "Big Boost to India's Fight Against COVID-19! Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation," Mandaviya tweeted. In the subsequent tweet he said, "This step will further strengthen our collective fight against the pandemic. "India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji's leadership. With the science-driven approach & Sabka Prayas, we will defeat COVID-19", he said. /IANS




Related

Eye camps banned in Kanpur after 8 lose eyesight
Kanpur, Nov 28 : The chief medical officer (CMO) of Kanpur has banned public and private hospitals from holding any eye check-up camps until further o

Cancer patient saved through rare surgery at KGMU
Lucknow, Nov 28 : Doctors at King George's Medical University (KGMU) saved the life of a 60-year-old oesophageal cancer patient by performing complex

Pakistan launches anti-polio vaccination drive to inoculate 13.5 mn children
Islamabad, Nov 28 : The Pakistani Health Ministry has launched the third anti-polio vaccination campaign of the year from Monday to vaccinate 13.5 mil